THC Biomed Intl Ltd.
THC Biomed Intl Ltd. (THCBF) Stock Overview
Explore THC Biomed Intl Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.4B
P/E Ratio
0.00
EPS (TTM)
$-0.01
ROE
0.00%
THCBF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of THC Biomed Intl Ltd. (THCBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 48.23, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
John Miller
35
2550 Acland Road, Kelowna, BC
2018